US President Joe Biden is set to announce a new set of guidelines this week that aim to protect the reproductive rights of women in the country. The announcement follows the overturning of the landmark Roe v. Wade ruling by the Supreme Court early this year.
Biden will announce the new guidelines and grants Tuesday that aim to protect reproductive rights during a meeting of the reproductive rights task force that will also be attended by Vice President Kamala Harris.
The US leader is also set to describe how abortion rights have been curtailed since the Conservative-majority Supreme Court overturned the 1973 ruling guaranteeing a woman’s right to have an abortion.
The meeting would mark 100 days since the high court overturned the ruling and will focus on how millions of women in the country are no longer allowed to access abortion services and how doctors and nurses are facing criminal penalties for providing such services, according to a White House official and a letter to Biden from Jen Klein, the head of the inter-agency task force on abortion access.
During the meeting, Biden is also set to talk about new guidelines for universities from the Education Department to protect students from discrimination on the basis of pregnancy and $6 million in new grants to protect access to reproductive healthcare from the Health and Human Services Department.
According to Klein’s letter, abortion bans have come into effect in over a dozen states since the Supreme Court overturned Roe v. Wade. Almost 30 million women of reproductive age are living in the state with an abortion ban in place, including 22 million women who cannot access abortion services after six weeks.
The letter by Klein also cited GOP Senator Lindsey Graham’s plan to introduce a national abortion ban.
Physicians and abortion rights advocates have now urged the Food and Drug Administration to get Danco Laboratories to seek the approval of mifepristone, a pill that is used in terminating early pregnancies at home for miscarriage management.
Danco, which is one of the two companies that make the pill, said it has no current plans to do so but will consider it in the future.


Trump Signals U.S. Nearing End of Military Goals in Iran War, Shifts Hormuz Responsibility to Regional Nations
Israel Defies Trump's Warning, Launches New Strikes on Iran Amid Growing Global Energy Crisis
Iran-Israel War Escalates: Long-Range Missiles, Nuclear Site Strikes, and Global Energy Crisis
Ukraine-U.S. Peace Talks Resume in Florida Amid Ongoing Russia-Ukraine War
Trump Signals End of U.S. Military Campaign Against Iran as Markets Rally
Trump Warns Israel as U.S.-Israeli War on Iran Triggers Global Energy Crisis
Trump White House Unveils National AI Policy Framework for Congress
Trump Presses Japan to Support Iran War Effort, Cites Pearl Harbor in Surprise Defense
Trump's Shifting War Goals Against Iran: A Timeline of Contradictions
US-Iran War: Trump Eyes Military Exit as Markets React to Potential De-escalation
S&P 500 Rebounds After Netanyahu's Statements on Iran's Military Setbacks
Trump Issues 48-Hour Ultimatum to Iran Over Strait of Hormuz, Threatens Power Grid Strikes
Cuba Rejects U.S. Demands to Remove President Diaz-Canel Amid Ongoing Negotiations
Federal Judge Blocks Pentagon's Restrictive Press Access Policy
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Ukraine-U.S. Peace Talks in Florida Target Ceasefire Framework and Defense Cooperation 



